| P2093 | author name string | Marcus J Zervos | |
| | Susan L Davis | |
| | Carol L Moore | |
| | Mary B Perri | |
| | Susan M Donabedian | |
| | Dora Vager | |
| | Thea Chua | |
| | Benjamin Zimnicki | |
| | Kaitlin Lulek | |
| | William Masch | |
| P2860 | cites work | Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia | Q28145964 |
| | Invasive methicillin-resistant Staphylococcus aureus infections in the United States | Q29616087 |
| | Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study | Q29616607 |
| | Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). | Q30453672 |
| | National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. | Q30977541 |
| | Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone | Q33686212 |
| | Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005 | Q33877838 |
| | Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus | Q34073407 |
| | Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin | Q34107062 |
| | Staphylococcus aureus resistant to vancomycin--United States, 2002. | Q34141070 |
| | Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections | Q34198417 |
| | The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges | Q34401421 |
| | Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community | Q34438505 |
| | High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm | Q34577836 |
| | Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 |
| | Application of molecular techniques to the study of hospital infection | Q34974995 |
| | Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis | Q35030135 |
| | Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods | Q35541702 |
| | Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors | Q35793612 |
| | Staphylococcus aureus strains that are hypersusceptible to resistance gene transfer from enterococci | Q35840823 |
| | Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection | Q35913984 |
| | Methicillin-resistant-Staphylococcus aureus hospitalizations, United States | Q36009453 |
| | Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection | Q36606071 |
| | The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus | Q36779557 |
| | Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database | Q37059039 |
| | Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak | Q39357855 |
| | Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides | Q39465279 |
| | Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections | Q39744021 |
| | Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA). | Q39793357 |
| | Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period | Q41066970 |
| | Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan | Q41915203 |
| | Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus. | Q42112490 |
| | Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States | Q42126345 |
| | A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides | Q42912582 |
| | Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. | Q43858066 |
| | Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. | Q44033264 |
| | Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? | Q44379429 |
| | Impact of methicillin-resistant Staphylococcus aureus on the incidence of nosocomial staphylococcal infections | Q44654741 |
| | Obvious lack of association between dynamics of epidemic methicillin-resistant Staphylococcus aureus in central Europe and agr specificity groups | Q44678030 |
| | Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy | Q44959085 |
| | Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997. | Q45079954 |
| | High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity | Q45302930 |
| | Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia | Q46554474 |
| | Staphylococcus aureus endocarditis: a consequence of medical progress | Q46561771 |
| | Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. | Q46766488 |
| | Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q46826194 |
| | Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia. | Q46879391 |
| | Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. | Q51785920 |
| | Comparison of Mortality Risk Associated With Bacteremia Due to Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus | Q61858155 |
| | Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05 | Q80595494 |
| | An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus | Q83230645 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| | Staphylococcus aureus | Q188121 |
| | methicillin-resistant Staphylococcus aureus | Q595158 |
| | urban ecology | Q1430301 |
| P304 | page(s) | 2345-2352 | |
| P577 | publication date | 2008-05-28 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit | |
| P478 | volume | 46 | |